Matter Bio is a longevity holding company focused on preserving genome integrity

As we age, our genome is constantly being damaged by exogenous and endogenous sources.

 Occasionally errors are missed and incorporated into the DNA in the form of mutations, structural variations, epigenetic drift, and other types of information loss.
 
At Matter, we have assembled a world-class team of scientists and executives to help counter this critical information loss in the genome.

To achieve this, we are focusing on a number of assets that address key stages in the genomic information loss continuum.

Matter Bio

Age is inevitable. Aging is not.
Matter Bioworks, Christopher Bradley, and Sam Sharifi, PhD are new members at ShareLab.

Matter Bio is a US longevity holding company focused on preserving genome integrity. Matter's core assets comprise accurate mutation sequencing, improving endogenous DNA repair, removing somatic mutations, and removing overly corrupted cells altogether. The company's current co-founders include Prof George Church (Harvard Medical School), Prof Jan Vijg, Assoc Profs Alexander Maslov and claudia Gravekamp (all three at Albert Einstein College of Medicine), and other top scientists. 

Sam will be running Matter Bio's campaign in the (Share)lab. He is Dutch, a biogerontologist with a PhD from the University of Jena.

#biotech #longevity #oslo #sharelab

BioMarin Pharmaceutical Inc. is a biotechnology company focusing on the development of therapeutics and diagnostics.

BioMarin Pharmaceutical Inc.

Clario is a biotechnology company known for its innovative approaches in the biotech sector.

Clario

BeiGene is a prominent biotechnology company involved in the development of biotech research services and therapeutics.

BeiGene

Revity is a biotechnology company known for its contributions to the biotech sector.

Revity

Ginkgo Bioworks is a biotechnology company specializing in the development of biocatalysts and sustainable manufacturing of pharmaceuticals and food.

Ginkgo Bioworks

Matter Bio is a company that appears to specialize in the biotechnology sector, potentially focusing on the development of therapeutics, diagnostics, or biotech research services.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Jun 24, 2024 3:14 AM	5c7cceaa
public peers	general	Jun 22, 2024 5:52 AM	4ade6baa
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 23, 2024 4:44 AM	a3f4cbc9
company summary	general
signals	general
crunchbase trigger	general	Oct 31, 2024 9:55 AM	33ede7e8
crunchbase profile	general
li profile	general	Jun 22, 2024 5:52 AM	9682110c
translate crunchbase fundingrounds	general
peers	general
news basic	general	Jun 22, 2024 5:52 AM	3307ba1f
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:MATTERBIO

Matter Bio